
|Videos|April 11, 2020
Weekly Webinar Series Part 3: Managing Lung Cancer Patients Through the COVID-19 Pandemic
Advertisement
Led by Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; H. Jack West, MD; and Tony Mok, MD, these top leaders in the lung cancer space shared insights on the novel corona-virus disease 2019 (COVID-19) and how the pandemic is poised to have a significant impact on lung cancer treatment and the healthcare system.
Topics include:
- Collaborative discussion on international perspective surrounding the COVID-19 pandemic
- Management strategies in patients with stage III non—small cell lung cancer who are at risk for COVID-19
- Next steps with treatment modifications to reduce risk of COVID-19 in patients with lung cancer
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5




































